The BioNTech [COVID-19] vaccine has shown greater take-up [in Hong Kong] since its launch. Over the past week, more than double the number of people have booked the BioNTech shot compared to Sinovac, according to government figures.
…the government had initially contacted Fosun Industrial (Hong Kong), the distributor, after it found some cases of cracks in vaccine containers and stains on some bottles.
…Fosun replied on Wednesday morning stating that it needed to further investigate and would suspend vaccination until further notice.
…Fosun's parent company, Shanghai Fosun Pharmaceutical, said in a filing on Wednesday it was investigating with BioNTech.
Doesn’t pass the sniff test, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.